uses theoretical modeling as a basis for understanding brain function. Because neurons in their neurophysiological workings can be understood as functioning according to an all-or-none principle (the neuron provides a uniform response to any stimulus above a certain threshold), they could be modeled according to the principles of logic. The collaboration with the mathematically gifted Pitts allowed McCulloch to present and develop his anti-dualist position.
The central pay-off of Abraham's biographical research is its contribution to our understanding of cybernetics. Building on existing literature that emphasizes the multi-disciplinary nature of the field, and paying attention to the contingencies of funding structures, institutional contexts, and personal relations, Abraham draws our attention to the interrelations between cybernetics and the life and medical sciences, not simply as fields to which insights from the physical sciences were applied (as, for instance in the vision of Norbert Wiener), but as driving forces of scientific inquiry. Ironically, this work leads Abraham to examine the limits of transdisciplinarity, for the man as well as for cybernetics. For while at first glance, McCulloch's itinerary might seem to provide a unifying thread that can tie together the divergent fields contributing to the cybernetic project, Abraham cautions us against assuming that the various aspects of a human life add up to a coherent whole. As she argues, McCulloch's attempts at self-fashioning and the "unified and universal rhetoric" (p. 5) that he used should be seen as a response to, rather than a denial of the fragmented nature of his endeavors: there was no common core to his multiple professional orientations nor to the cybernetic projects on which he labored. Transdisciplinarity, for McCulloch himself and for the larger cybernetic enterprise, always remained an ideal. "The practice of medicine in 1980 looked quite a bit different than it had in 1930," write Jeremy Greene, Elizabeth Watkins, and Flurin Condrau, in the introduction to Therapeutic Revolutions (p. 8). A major component of the transformation of medicine in these decades was the massive expansion of pharmaceutical research and development that led to the introduction of scores of new prescription drugs, including antibiotics, corticosteroids, minor and major tranquilizers, oral contraceptives, and the first drugs to treat hypertension. This period of transformation has been termed by physicians, the pharmaceutical industry, policy makers, patients, and some medical historians alike as a therapeutic revolution. But as Charles Rosenberg noted forty years ago in his seminal essay, "The Therapeutic Revolution," claims of therapeutic efficacy-and thus the basis of therapeutic revolution-are both historically contingent and locally specific.
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This impressive collection of essays by leading scholars in the history and anthropology of pharmaceuticals builds on Rosenberg's earlier analysis to problematize the concept of a twentieth-century pharmacotherapeutic revolution. By examining the intersections of pharmaceutical innovation and social transformation in North America, Western Europe, and Africa, the essays underscore the historical contingency and geographic specificity of any such revolution, and reveal what was at stake politically, economically, and culturally for the various historical actors that have mobilized the language of therapeutic revolution.
The volume can be broken into four sections. The first section, with chapters by Scott Podolsky and Anne Kveim Lie, Elizabeth Watkins, and Nicolas Henckes, considers three classes of drugs held as emblematic of the mid-twentieth-century therapeutic revolution-antibiotics, oral contraceptives, and antipsychotics, respectively-and examines the degree to which these drugs were revolutionary and the political, economic, and social gains made by those who mobilized the rhetoric of revolution.
The second section interrogates the measures by which pharmaceuticals introduced in the mid-twentieth century were considered revolutionary: pharmaceutical consumption and statistical measurements of therapeutic efficacy. Using pharmaceutical sales data from IMS Health, Nils Kessel and Christian Bonah show that it was older drug products like analgesics, hypnotics, and sedatives, rather than "revolutionary medicines" like antibiotics and cardiovascular drugs, that dominated the West German pharmaceutical market in the 1960s and 1970s. In their history and ethnography of tuberculosis treatment, Janina Kehr and Flurin Condrau show the ways in which clinical trials data documenting the efficacy of streptomycin to treat tuberculosis in the 1950s was mobilized as "proof of the universal effectiveness of antibiotics regardless of social situation," even as antibiotic resistance undermined treatment efforts and tuberculosis persisted as a global health concern (p. 135). This "statistical modeling of success" (p. 135), Kehr and Condrau argue, "transformed tuberculosis from a subject of cutting-edge biomedical research into a disease that physicians considered 'boring' . . . until it reemerged in the late twentieth century as multidrug resistant tuberculosis and extremely drug-resistant tuberculosis, and thus a subject of renewed biomedical excitement" (p. 12).
The third section shifts focus from the United States and Western Europe to the Global South and examines the intersections of pharmaceutical innovation, international development, and global public health, highlighting the spatialtemporal character and political economy of the therapeutic revolution. Jeremy Greene analyzes the ways in which American lawmakers, physicians, patients, regulators, and pharmaceutical companies mobilized arguments about the cause of and potential solutions to geographic disparities in pharmaceutical access during the 1960s and 1970s in an attempt to shape both domestic health policy and international development agendas. Paul Farmer, Matthew Basilico, and Luke Messac revisit the debate, ignited by Thomas McKeown in the 1960s, over the role of medicine in public health. Their analysis of recent economic, ethnographic, and epidemiological data makes clear that despite the persistent problem of uneven access, pharmaceuticals have contributed to a significant population-level mortality decline in the Global South. Julie Livingston's history and ethnography of cancer treatment in Botswana makes clear the unintended consequences for patients and health care providers of a global health agenda that has prioritized the provision of revolutionary medicines like antiretrovirals, over the provision of more mundane pharmaceuticals like analgesics and antiemetics. Kristin Peterson's ethnography of a wholesale pharmaceutical market in Nigeria reveals that the production and circulation of drugs-mostly low-end, low-cost, largely inefficacious, and often faked drugs-in West Africa is critically linked to the neoliberal restructuring of the Nigerian state and the "speculative practices of the drug industry (such as massive mergers and investments in highrisk biotech companies)" in the 1980s (p. 239). As multinational pharmaceutical firms capitalized on the revolutionary promise of the new biotechnology, the only "therapeutic revolution to be found in Nigerian drug markets," Peterson argues, "was innovation in new ways to fake drugs, and not the realization of new and much-needed therapeutics" (p. 239).
In the final section, David Jones analyzes the ways physicians and researchers have mobilized the metaphors of evolution and revolution to characterize the nature of therapeutic change over the course of the twentieth century, and Charles Rosenberg reflects on the meaning, value, and limits of the concept of therapeutic revolution, forty years after he first published on the subject.
Therapeutic Revolutions makes a valuable contribution to the history of twentiethcentury medicine. The geographic breadth of the analysis complicates and provides texture to our understanding of the medical, political, and cultural changes wrought by the introduction of new pharmaceuticals in the mid-twentieth century. The book's engaging and clear prose will make this an excellent contribution to undergraduate teaching on twentieth-century medicine. In the introduction, the editors ask, "What is revolutionary about therapeutics?" (p. 2). By the volume's end, it's clear the answer depends on where, for whom, and by what measures change occurred.
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